Question 1

A female patient has been prescribed warfarin (Coumadin)in addition to a heparin infusion.What is the reason for her receiving two anticoagulants?

Accepted Answer

A) The oral and injection forms work synergistically. 
B) The combination of heparin and an oral anticoagulant results in fewer adverse effects than heparin used alone. 
C) Oral anticoagulants are used to reach an adequate level of anticoagulation when heparin alone is unable to do so. 
D) When oral anticoagulants are prescribed, heparin is often used to initiate therapy until laboratory tests indicate an adequate therapeutic response. 
A) The oral and injection forms work synergistically. 
B) The combination of heparin and an oral anticoagulant results in fewer adverse effects than heparin used alone. 
C) Oral anticoagulants are used to reach an adequate level of anticoagulation when heparin alone is unable to do so. 
D) When oral anticoagulants are prescribed, heparin is often used to initiate therapy until laboratory tests indicate an adequate therapeutic response. D

Question 2

Which drug is the recommended antidote for heparin toxicity?

Accepted Answer

A) Vitamin E 
B) Vitamin K 
C) Protamine sulphate 
D) Potassium phosphate 
A) Vitamin E 
B) Vitamin K 
C) Protamine sulphate 
D) Potassium phosphate C

Question 3

A patient has started on anticoagulant drugs.What is the primary goal of this therapy?

Accepted Answer

A) To prevent thrombus formation 
B) To dissolve an existing thrombus 
C) To stabilize an existing thrombus 
D) To prevent the thrombus from becoming an embolus 
A) To prevent thrombus formation 
B) To dissolve an existing thrombus 
C) To stabilize an existing thrombus 
D) To prevent the thrombus from becoming an embolus A

Question 4

Which statement is true for the patient receiving long-term therapy with acetylsalicylic acid (aspirin)?

Accepted Answer

A) Aspirin should be taken on an empty stomach to ensure maximal absorption. 
B) Bleeding tendencies are not of much concern to those taking Aspirin therapy. 
C) Laboratory studies should be done to monitor liver, renal, and clotting functions. 
D) Development of a rash is expected and does not warrant discontinuing the medication. 
A) Aspirin should be taken on an empty stomach to ensure maximal absorption. 
B) Bleeding tendencies are not of much concern to those taking Aspirin therapy. 
C) Laboratory studies should be done to monitor liver, renal, and clotting functions. 
D) Development of a rash is expected and does not warrant discontinuing the medication.

Question 5

A patient is taking anticoagulant therapy.Which natural health product should the patient avoid taking?

Accepted Answer

A) Valerian 
B) Ginkgo 
C) St.John's wort 
D) Saw palmetto 
A) Valerian 
B) Ginkgo 
C) St.John's wort 
D) Saw palmetto

Question 6

The nurse is administering heparin subcutaneously.
Which instruction for doing this is correct?

Accepted Answer

A) Aspirate before injecting. 
B) Massage site after injection. 
C) Apply heat to the injection site. 
D) Use a new, sterile 1.5-cm 25- to 28-gauge needle for the injection. 
A) Aspirate before injecting. 
B) Massage site after injection. 
C) Apply heat to the injection site. 
D) Use a new, sterile 1.5-cm 25- to 28-gauge needle for the injection.

Question 7

Which laboratory study is used to monitor the therapeutic effects of warfarin (Coumadin)?

Accepted Answer

A) International normalized ratio 
B) aPTT 
C) Vitamin K 
D) Hematocrit 
A) International normalized ratio 
B) aPTT 
C) Vitamin K 
D) Hematocrit

Question 8

What is the recommended antidote for warfarin (Coumadin)toxicity?

Accepted Answer

A) Vitamin E 
B) Vitamin K 
C) Protamine sulphate 
D) Potassium phosphate 
A) Vitamin E 
B) Vitamin K 
C) Protamine sulphate 
D) Potassium phosphate

Question 9

A male patient will be receiving streptokinase as part of the treatment of acute myocardial infarction.He asks why he is being prescribed this drug.The nurse's best response is to tell him that the drug is being prescribed to

Accepted Answer

A) relieve chest pain. 
B) prevent further clot formation. 
C) dissolve the clot in his coronary artery. 
D) control bleeding in the coronary microcirculation. 
A) relieve chest pain. 
B) prevent further clot formation. 
C) dissolve the clot in his coronary artery. 
D) control bleeding in the coronary microcirculation.

Question 10

A patient who is taking warfarin (Coumadin)therapy has a headache and wants to take a pain reliever.Which action is recommended?

Accepted Answer

A) Taking acetylsalicylic acid (Aspirin) tablets 
B) Taking ibuprofen (Advil), a nonsteroidal anti-inflammatory drug (NSAI
D)  
C) Taking acetaminophen (Tylenol) 
D) Calling the physician's office an order for an opioid 
A) Taking acetylsalicylic acid (Aspirin) tablets 
B) Taking ibuprofen (Advil), a nonsteroidal anti-inflammatory drug (NSAI
D)  
C) Taking acetaminophen (Tylenol) 
D) Calling the physician's office an order for an opioid

Question 11

Which laboratory study is used to monitor the therapeutic effects of heparin?

Accepted Answer

A) Prothrombin time 
B) Activated partial thromboplastin time (aPTT) 
C) Vitamin K 
D) Hematocrit 
A) Prothrombin time 
B) Activated partial thromboplastin time (aPTT) 
C) Vitamin K 
D) Hematocrit

Question 12

What is the most frequent adverse effect of thrombolytic therapy?

Accepted Answer

A) Dysrhythmia 
B) Nausea and vomiting 
C) Anaphylactic reactions 
D) Internal and superficial bleeding 
A) Dysrhythmia 
B) Nausea and vomiting 
C) Anaphylactic reactions 
D) Internal and superficial bleeding

Question 13

Which is a true statement about dipyridamole (Persantine)?

Accepted Answer

A) It has anti-inflammatory and antipyretic properties. 
B) It has analgesic properties and antithrombotic effects. 
C) It is useful for reducing the risk of fatal and nonfatal thrombotic stroke. 
D) It is used as an adjunct to warfarin in the prevention of postoperative thromboembolic complications. 
A) It has anti-inflammatory and antipyretic properties. 
B) It has analgesic properties and antithrombotic effects. 
C) It is useful for reducing the risk of fatal and nonfatal thrombotic stroke. 
D) It is used as an adjunct to warfarin in the prevention of postoperative thromboembolic complications.

Exam 27: Coagulation Modifier Drugs

A female patient has been prescribed warfarin (Coumadin)in addition to a heparin infusion.What is the reason for her receiving two anticoagulants?

Which drug is the recommended antidote for heparin toxicity?

A patient has started on anticoagulant drugs.What is the primary goal of this therapy?

Which statement is true for the patient receiving long-term therapy with acetylsalicylic acid (aspirin)?

A patient is taking anticoagulant therapy.Which natural health product should the patient avoid taking?

The nurse is administering heparin subcutaneously. Which instruction for doing this is correct?

Which laboratory study is used to monitor the therapeutic effects of warfarin (Coumadin)?

What is the recommended antidote for warfarin (Coumadin)toxicity?

A male patient will be receiving streptokinase as part of the treatment of acute myocardial infarction.He asks why he is being prescribed this drug.The nurse's best response is to tell him that the drug is being prescribed to

A patient who is taking warfarin (Coumadin)therapy has a headache and wants to take a pain reliever.Which action is recommended?

Which laboratory study is used to monitor the therapeutic effects of heparin?

What is the most frequent adverse effect of thrombolytic therapy?

Which is a true statement about dipyridamole (Persantine)?

Nursing Practice in Canada and Drug Therapy

Pharmacological Principles

Legal and Ethical Considerations

Patient Focused Considerations

Gene Therapy and Pharmacogenomics

Medication Errors: Preventing and Responding

Patient Education and Drug Therapy

Over-the-Counter Drugs and Natural Health Products

Vitamins and Minerals

Principles of Drug Administration

Analgesic Drugs

General and Local Anaesthetics

Central Nervous System Depressants and Muscle Relaxants

Central Nervous System Stimulants and Related Drugs

Antiepileptic Drugs

Antiparkinsonian Drugs

Psychotherapeutic Drugs

Substance Misuse

Adrenergic Drugs

Adrenergic-Blocking Drugs

Cholinergic Drugs

Cholinergic-Blocking Drugs

Antihypertensive Drugs

Antianginal Drugs

Heart Failure Drugs

Antidysrhythmic Drugs

Antilipemic Drugs

Diuretic Drugs

Fluids and Electrolytes

Pituitary Drugs

Thyroid and Antithyroid Drugs

Antidiabetic Drugs

Adrenal Drugs

Women’s Health Drugs

Men’s Health Drugs

Antihistamines,Decongestants,Antitussives,and Expectorants

Respiratory Drugs

Acid-Controlling Drugs

Antidiarrheal Drugs and Laxatives

Antiemetic and Anti-nausea Drugs

Nutritional Supplements

Antibiotics, Part 1: Sulfonamides, Penicillins, Cephalosporins, Macrolides, and Tetracyclines

Antibiotics Part 2: Aminoglycosides, Fluoroquinolones, and Other Drugs

Antiviral Drugs

Antitubercular Drugs

Antifungal Drugs

Antimalarial, Antiprotozoal, and Anthelmintic Drugs

Anti-Inflammatory and Antigout Drugs

Immunosuppressant Drugs

Immunizing Drugs and Pandemic Preparedness

Antineoplastic Drugs Part 1: Cancer Overview and Cell Cycle–Specific Drugs

Antineoplastic Drugs Part 2: Cell Cycle–Nonspecific and Miscellaneous Drugs

Biological Response–Modifying Drugs

Anemia Drugs

Dermatological Drugs

Ophthalmic Drugs

Otic Drugs

Filters